A24's new documentary regarding the Theranos scandal has set a two-decade benchmark for the genre's opening performance. this surge comes alongside a rebranded horror reboot and a variety of action and period films fighting for screen space this week.
The $7 million bet on Elizabeth Holmes
The documentary You Can See Everything,produced by A24, has emerged as a significant financial surprise. According to the report, the film was developed over three years with a budget of approximately $7 million, yet it managed to secure a $7.1 million opening weekend across 1,778 theaters. This performance marks the strongest opening for a documentary in twenty years.
The film's success appears to be driven by a younger audience, with exit-poll data showing that nearly 70% of viewers were under the age of 35. Furthermore, 90% of those viewers stated they would definitely recommend the movie, suggesting that the true story of Elizabeth Holmes and her company, Theranos, has struck a chord with Gen Z and Millennial demographics.
Comparing the $40 million Melania budget to A24's efficiency
The efficiency of A24's release highlights a shifting landscape in the documentary sector. As the report says, Amazon's MGM documentary Melania previously set a high bar for non-music documentaries, but it required a $40 million budget to achieve a $7.1 million opening from 1,778 theaters. The fact that You Can See Everything matched that opening figure with a fraction of the investment suggests a move toward leaner, buzz-driven productions over high-cost prestige projects.
This trend indicates that word-of-mouth, particularly following high-profile premieres like the one at Telluride, can be more valuable than a massive marketing spend. The ability of an arthouse release to achieve landmark numbers suggests that audiences are increasingly willing to seek out specialized non-fiction content in theaters rather than waiting for streaming releases.
Brendan Fraser and the rebranding of The Mummy: The Book of the Dead
In the realm of big-budget reboots, the hororr franchise starring Brendan Fraser and Rachel Weisz has undergone a strategic name change. Originally listed in press mailings as The Mummy 4, the film is now titled The Mummy: The Book of the Dead. This shift likely aims to distance the project from the baggage of previous sequels and position it as a fresh entry in the supernatural thriller market.
Other genre entries are seeing varied results. Paramount's Street Fighter, starring Noah Centineo and Andrew Koji, has reported $51.1 million in worldwide earnings, with $20.1 million of that coming from overseas markets. This suggests that video game adaptations continue to find stronger footing in international territories than in domestic ones.
Whalefall's $60 million struggle and the B-grade CinemaScore
Not every high-budget venture has found success this season. Disney and 20th Century's thriller Whalefall cost $60 million to produce but opened to a disappointing $8 million from 3,065 locations.. The film's struggle is compounded by a B-grade CinemaScore, indicating that the general audience's reception has been lukewarm at best.
In contrast, niche offerings are finding small but steady pockets of interest. A Focus Features remake of Jane Austen's Sense and Sensibility earned $7.2 million from 2,545 screens, benefiting from a growing appetite among younger viewers for historical period dramas.
The 70% drop for Other Mommy and the mystery of the summer slate
Despite being the highest-grossing summer title with $44.8 million domestically, the horror film Other Mommy is showing signs of instability. The film experienced a steep 70% decline in earnings during its second weekend, despite its modest $18 million budget. This volatility raises questions about the longevity of current summer hits and whether the market is becoming oversaturated with horror content.
There remain several unanswered points regarding the current theatrical climate. Specifically, it is unclear why Whalefall failed to connect with audiences despite its massive distribution, and whether the success of You Can See Everything is a fluke of the Theranos brand or a sustainable model for A24's future documentary slate. Additionally, the source does not provide data on whether The Mummy: The Book of the Dead has secured strong pre-sale numbers following its rebranding.
Comments 0